You may have seen me refer in the past to some of the clinical trials I’ve been involved in. Now it’s time for the next phase of news! The “Baker AAPS” trial In 2019 I started working with the Baker Heart & Diabetes Institute on a clinical trial of the safety and efficacy of the …
I’ve written numerous times about modelling the activity profiles of various insulins. Telling my oref-based Automated Insulin Delivery (AID) system which insulin I’m using lets it model the current situation (and forecast the future) quite well. We usually think about this in terms of the simple concept of a single bolus: how quickly it starts …
Different insulins have effect (and get used up) at different speeds, and modelling this is important for accurate calculation of subsequent insulin doses. Some automated insulin delivery (AID) systems try to determine this themselves (e.g. CamAPS has nowhere for us to tell it which insulin we’re using) and some (e.g. Medtronic and Control-IQ) seem to …
In my recent “Pancreas phone” options post I listed some of the small Android phones people have been using for diabetes management lately. This post is a brief update on that. Cubot KingKong Mini 3 I mentioned the KingKong Mini 3 and Pocket 3 models (which seem to share the same internals, just with the …
Yes, the Omnipod DASH is soon to be subsidised through NDSS. People have been asking for this for a while (pretty much since the pods were introduced a year ago). The new subsidy will apparently become effective on the 1st of December. Hopefully this means that the appropriate registration forms can be processed and training …
In the last day there have been some sensational claims on networks like 9News about Omnipods possibly catching fire. Luckily this is just tabloid journalism at its “finest”, including bogus claims that the wearable device may catch fire. I’ll try to clarify. There is no “product recall”. There is no risk that the pods will …